The NCCN 17th Annual Conference will take place March 14 – 18 at The Westin Diplomat in Hollywood, Florida. This year's conference features two roundtable discussions, Cancer and Corporate America: Business as Usual? and Optimal Care for Patients: Who Decides? New NCCN Guidelines for Acute Lymphoblastic Leukemia, Adolescent and Young Adult (AYA) Oncology, and Lung Cancer Screening will also be presented.
FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®) will hold the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™, March 14 - 18 at The Westin Diplomat in Hollywood, Florida. More than 1,500 physicians, nurses, pharmacists, and other oncology professionals and representatives of the business sector are expected to attend.
This year's conference features two roundtable discussions focused on key issues related to the delivery of cancer care. Long time NCCN moderator, ABC News veteran and anchor, Sam Donaldson, will open the conference on Thursday morning by leading a distinguished panel of experts in a roundtable discussion entitled: Cancer and Corporate America: Business as Usual? The panel includes Robert W. Carlson, MD, an oncologist from Stanford Cancer Institute; Helen Darling, President and Chief Executive Officer of the National Business Group on Health; John S. Greene, Director of Engineering from Salesforce.com; Carole Klase, PhD, a cancer survivor; J. Randall McDonald, Senior Vice President of Human Resources for IBM; Sheri S. McCoy, MSc, MBA, Vice Chairman of the Executive Committee of Johnson and Johnson; Kavita Patel, MD, MSHS, of the Brookings Institution's Engelberg Center for Health Care Reform; and J. Brent Pawlecki, MD, MMM, Chief Health Officer of The Goodyear Tire & Rubber Company.
"For the last fifteen months, NCCN has been working closely with the National Business Group on Health, and we have come to understand how important it is to corporations to assure that their employees have access to the highest quality of cancer care and to ensure that they receive value for the services delivered to those employees." said Patricia J. Goldsmith, NCCN Executive Vice President/Chief Operating Officer. "We have brought together an outstanding group of experts to discuss the opportunities and the barriers that exist for companies in identifying and delivering quality cancer care, and we are delighted to have my dear friend Sam Donaldson with us again this year to lead the discussion."
The second roundtable discussion, Optimal Care for Patients: Who Decides? opens the Friday sessions. Clifford Goodman, PhD, of the Lewin Group, will moderate this panel which will delve into the difficult issues related to balancing patient needs and desires with the economic and clinical realities of making treatment decisions. Joining Dr. Goodman are Karen Alban, RN, BSN, OCN, of the Oncology Nursing Society; Al B. Benson III, MD, of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Nancy Davenport-Ennis of the National Patient Advocate Foundation; Scott Gottlieb, MD, of the American Enterprise Institute; Shari M. Ling, MD, of the Centers for Medicare & Medicaid Services (CMS); Ray Lynch, CPA, MBA, of the Huntsman Cancer Institute; Lee N. Newcomer, MD, MHA, of UnitedHealthcare; and David G. Pfister, MD, of Memorial Sloan-Kettering Cancer Center.
This panel represents the full range of people involved in the decision making process—patients, physicians, providers, corporations, CMS, and private insurers. The panel will examine the problems from diverse perspectives and then discuss the issues.
This year's conference will feature sessions on three new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Acute Lymphoblastic Leukemia, Adolescent and Young Adult (AYA) Oncology, and Lung Cancer Screening. The NCCN Guidelines® for AYA Oncology are the first such guidelines to address the full spectrum of clinical and psychosocial issues that patients between the ages of 15 to 39 face when they are diagnosed with cancer. Updates for more than 10 additional NCCN Guidelines will also be presented, including, but not limited to, Melanoma, Non-Hodgkin's Lymphomas, and Hodgkin Lymphoma. The full conference agenda is available at NCCN.org. Press inquiries and requests for interviews should be addressed to C. Lyn Fitzgerald at firstname.lastname@example.org.
The NCCN Guidelines are developed and updated through an evidence-based process in which the expert panel integrates comprehensive clinical and scientific data with the judgment of the multidisciplinary panel members and other experts drawn from NCCN Member Institutions. Access to the NCCN Guidelines for AYA Oncology or any of the NCCN Guidelines is available free of charge at NCCN.org.
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 23 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.